Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, today announced the closing of an oversubscribed...
Cambium, a pioneer in advanced materials for high-performance sectors, announced the acquisition of Sleaford, U.K.-based SHD Group, a global advanced composites manufacturer with production...
Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced the closing of the $25M final...
Atavistik Bio, a biotechnology company discovering the next generation of precision allosteric therapeutics, today announced that it has raised a $120 million Series B...
Axion, the pioneering AI platform for manufacturing product quality, today announced a $37 million Series B funding round led by Salesforce Ventures with participation...
Chai Discovery is an applied research lab working to turn biology from a scientific practice into an engineering discipline. We build models that can...
Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing. Proceeds will fund...
